| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,308 | 0,344 | 09:46 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.07. | Cambridge Cognition reports 16% revenue growth in first half | 3 | Investing.com | ||
| 27.07. | Cambridge Cognition - Trading Update | - | RNS | ||
| 22.07. | Cambridge Cognition - TR-1: Notification of Major Holdings | - | RNS | ||
| 15.07. | Cambridge Cognition - TR-1: Notification of Major Holdings | - | RNS | ||
| 10.07. | Cambridge Cognition - Result of GM, TVR & Director/PDMR Dealing | - | RNS | ||
| 30.06. | Cambridge Cognition - Result of Retail Offer | - | RNS | ||
| 24.06. | Cambridge Cognition - Retail Offer | - | RNS | ||
| 24.06. | Cambridge Cognition - Result of Placing & Posting of Circular | - | RNS | ||
| CAMBRIDGE COGNITION Aktie jetzt für 0€ handeln | |||||
| 23.06. | IN BRIEF: Cambridge Cognition raises cash to fund next stage of growth | 1 | Alliance News | ||
| 23.06. | Cambridge Cognition - Proposed Equity Fundraising and Retail Offer | - | RNS | ||
| 01.06. | Cambridge Cognition - COG to present at Mello 2026 | - | RNS | ||
| 28.05. | Cambridge Cognition - Launch of brain health study with Oura | - | RNS | ||
| 21.05. | Cambridge Cognition - Result of AGM | - | RNS | ||
| 24.04. | Cambridge Cognition - Posting of Annual Report & Notice of AGM | - | RNS | ||
| 13.04. | Cambridge Cognition - Results for the year ended 31 December 2025 | - | RNS | ||
| 07.04. | Cambridge Cognition - Notice of Results | - | RNS | ||
| 07.04. | Cambridge Cognition - Appointment of Nominated Adviser and Joint Broker | - | RNS | ||
| 17.02. | Cambridge Cognition Holdings plc: Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway in India | 421 | Business Wire | Cambridge Cognition Holdings plc ("Cambridge Cognition") (AIM: COG), the neuroscience technology company specialising in digital cognitive assessments, and Ivory, a venture-backed brain health company... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 57,88 | 0,00 % | BrightSpring auf Wells Fargo Konferenz: Wachstum beschleunigt sich auf breiter Front | ||
| TENON MEDICAL | 5,340 | +0,75 % | Morning Market Movers: Tenon Medical, Shoe Station, Cooper Companies, Culp, Inc. See Big Swings | TOKYO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 12,760 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| AVEANNA HEALTHCARE | 13,860 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,370 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| ADAPTHEALTH | 5,850 | 0,00 % | Truist reiterates Buy on AdaptHealth stock after CFO change | ||
| PROGYNY | 27,080 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| HEARTFLOW | 45,470 | -0,04 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,000 | 0,00 % | LifeStance prices 22.3 million share secondary offering at $12.35 | ||
| PROCEPT BIOROBOTICS | 20,070 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| BILLIONTOONE | 98,67 | +0,16 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GENEDX | 83,97 | +0,01 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BETA BIONICS | 16,590 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PACS GROUP | 44,820 | -0,04 % | Truist reiterates Buy on PACS Group stock after Florida deal | ||
| CLEARPOINT NEURO | 13,480 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen |